News and features

Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future.

'We Dance for Life', a creative film that celebrates scientists from The Institute of Cancer Research, London, and The London Cancer Hub, has won the Best Dance Experimental award at the Experimental, Dance & Music Film Festival in the USA and Canada.

Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to the IMPORT HIGH trial.

An international study led by ICR scientists has accurately categorised tumour and immune cells of non-human animal species by applying an artificial intelligence (AI) algorithm that was trained on human lung cancer samples.

Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown.

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential.

A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study.

Researchers have revealed, at high-resolution, the structure of a human protein complex named SIN3B, which is a ‘nanomachine’ involved in regulating cell division – a fundamental process for life which, if it becomes uncontrolled, can lead to cancer.

Pancreatic cancer cells can change their ‘diet’ to keep growing, by switching from the sugar glucose to a back-up fuel called uridine, new research reveals.

England’s first centre of its kind is set to make significant improvements in cancer diagnosis and treatment – by combining pioneering digital imaging with artificial intelligence.

Scientists have uncovered the inner workings of one of the most important and intricate ‘nanobots’ operating within our cells – using cutting-edge microscopy for visualising molecules almost at an atomic level. Their new study published in Nature has unveiled the critical step that switches on the spliceosome – a piece of cellular machinery that enables cells to build complex proteins.

Professor Kristian Helin, a world-leading cancer researcher and Chief Executive of The Institute of Cancer Research, London, has been elected as a Foreign Member of the Royal Society in recognition of his outstanding contribution to cancer research.